Iovance Biotherapeutics
IOVA
IOVA
153 hedge funds and large institutions have $1.12B invested in Iovance Biotherapeutics in 2019 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 36 increasing their positions, 49 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.19% less ownership
Funds ownership: 96.25% → 95.06% (-1.2%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
27% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 49
Holders
153
Holding in Top 10
7
Calls
$1.33M
Puts
$238K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$10.8M | |
| 3 | +$7.91M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$7.65M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$4.4M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$15.4M | |
| 3 | -$7.14M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$5.21M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.96M |